Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02577952 · ClinicalTrials.gov registry record
Lipodystrophy Connect Patient Registry
A clinical trial of Lipodystrophy, sponsored by PatientCrossroads.
- Completed
- Registry status
- 257
- Enrollment target
- 1
- Study location
NCT02577952 is a study of Lipodystrophy that has completed, run by PatientCrossroads. The registered enrollment target is 257 participants, above the 110-participant average among 11 other Lipodystrophy trials with a reported enrollment target (134% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02577952, a study of Lipodystrophy, has completed, sponsored by PatientCrossroads.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
- 1
- Study location
Study Summary
Lipodystrophy Connect is an online survey tool designed to collect demographic data and health information from individuals with Lipodystrophy.
Conditions Studied
Study Locations (1)
California
- PatientCrossroads - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2014-01 |
| Est. Completion | 2018-11-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02577952
The ClinicalTrials.gov registry entry for NCT02577952 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 110-participant average among 11 other Lipodystrophy trials with a reported enrollment target (134% higher). The listed sponsor is PatientCrossroads, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lipodystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT02577952 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02577952 about?
NCT02577952 is a clinical study titled "Lipodystrophy Connect Patient Registry". Lipodystrophy Connect is an online survey tool designed to collect demographic data and health information from individuals with Lipodystrophy.
What is the current status of trial NCT02577952?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2014-01. Estimated completion is 2018-11-08.
What conditions does trial NCT02577952 study?
This clinical trial studies the following conditions: Lipodystrophy.
Who is sponsoring clinical trial NCT02577952?
This trial is sponsored by PatientCrossroads, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02577952 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lipodystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
RECRUITING
-
Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
RECRUITING
-
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
ACTIVE NOT RECRUITING · Phase 2
-
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
COMPLETED · Phase 2
-
Exercise and Pioglitazone for HIV-Metabolic Syndromes
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.